Condition

Type 2 Diabetes Mellitus (T2D)

ClinicalTrials.gov condition label

Clinical trials4

Recruiting1

Common interventions5

Lead sponsors shown4

Clinical trials

4 shown

Culturally Tailored Program for Food-Insecure Adults: SPICE-DNCT07361341 · 2026-04-01

Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)NCT07639684 · 2027-04-01

NOT_YET_RECRUITING

A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese ParticipantsNCT06869018 · 2025-05-07

Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in FranceNCT01552005 · 2012-05-01

Common interventions

ESG with OverStitchDEVICE1 Food Bundle InterventionOTHER1 LY3549492DRUG1 PlaceboDRUG1 SaxagliptinDRUG1

Leading sponsors

AstraZeneca1 Boston Scientific Corporation1 Eli Lilly and Company1 Wake Forest University Health Sciences1

Trial status mix

COMPLETED2

NOT_YET_RECRUITING1

RECRUITING1

Phase mix

NA2

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.